High Risk Her2 Positive Breast Cancer clinical trials

Explore recruiting high risk her2 positive breast cancer clinical trials.

Recruiting high risk her2 positive breast cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

High Risk Her2 Positive Breast Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Multicenter, Randomized, Open-Label, Active-Controlled Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in Subjects with High-Risk HER2-Positive Primary Breast Cancer Who Have Residual Invasive Disease in Breast or Axillary Lymph Nodes Following Neoadjuvant Therapy

Czechia, Poland, Germany, Netherlands, Spain, Ireland +7 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

High Risk Her2 Positive Breast Cancer trials by city

High Risk Her2 Positive Breast Cancer in Toronto High Risk Her2 Positive Breast Cancer in Vancouver High Risk Her2 Positive Breast Cancer in Montreal High Risk Her2 Positive Breast Cancer in Calgary High Risk Her2 Positive Breast Cancer in Edmonton High Risk Her2 Positive Breast Cancer in Ottawa High Risk Her2 Positive Breast Cancer in Winnipeg High Risk Her2 Positive Breast Cancer in Quebec City High Risk Her2 Positive Breast Cancer in Hamilton High Risk Her2 Positive Breast Cancer in Kitchener High Risk Her2 Positive Breast Cancer in London High Risk Her2 Positive Breast Cancer in Halifax High Risk Her2 Positive Breast Cancer in New York High Risk Her2 Positive Breast Cancer in Los Angeles High Risk Her2 Positive Breast Cancer in Chicago High Risk Her2 Positive Breast Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease